You have 9 free searches left this month | to do more
Showing 1 - 25 of
136 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Not yet recruiting
  • Graves Ophthalmopathy
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-11-16
Nov 16, 2021
U
Not yet recruiting
  • Graves' Orbitopathy
  • Pisa, PI, Italy
    Endocrinology Unit II
2022-02-01
Feb 1, 2022
U
Not yet recruiting
  • Graves Ophthalmopathy
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
2022-02-17
Feb 17, 2022
U
Not yet recruiting
  • Graves' Orbitopathy
  • Atorvastatin 20mg
  • Placebo
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
2021-09-08
Sep 8, 2021
J
Recruiting
  • Graves Ophthalmopathy
  • Bimatoprost Ophthalmic
  • Seattle, Washington
    University of Washington
2022-03-08
Mar 8, 2022
U
Completed
  • Thyroid Associated Ophthalmopathy
  • Hypercholesterolemia
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
2021-08-12
Aug 12, 2021
U
Completed
  • Graves Ophthalmopathy
  • No Intervention
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
2020-07-22
Jul 22, 2020
F
Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
2021-05-07
May 7, 2021
H
Completed
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Placebo
  • Beverly Hills, California
  • +13 more
2022-01-31
Jan 31, 2022
U
Not yet recruiting
  • Thyroid Associated Ophthalmopathy
  • (no location specified)
2020-03-24
Mar 24, 2020
M
Completed
  • Graves Disease
  • +5 more
  • Intravenous Methylprednisolone
  • (no location specified)
2020-05-13
May 13, 2020
H
Completed
  • Thyroid Eye Disease
  • Teprotumumab
  • Beverly Hills, California
  • +12 more
2021-12-09
Dec 9, 2021
H
Approved for marketing
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Beverly Hills, California
  • +7 more
2020-03-13
Mar 13, 2020
U
Completed
  • Graves Ophthalmopathy
  • +2 more
  • Serum antibodies against the IGF-1R
  • Pisa, Italy
    Endocrinology Unit I, University of Pisa
2018-07-26
Jul 26, 2018
M
Completed
  • Graves Disease
  • +13 more
  • every week IVMP therapy
  • very high doses IVMP therapy
  • (no location specified)
2018-09-11
Sep 11, 2018
M
Completed
  • Graves Disease
  • +4 more
  • (no location specified)
2018-07-17
Jul 17, 2018
P
Completed
  • Graves' Disease
  • +3 more
  • (no location specified)
2018-05-12
May 12, 2018
U
Completed
  • Graves Ophthalmopathy
  • No intervention
  • (no location specified)
2018-02-09
Feb 9, 2018
U
Completed
  • Graves Orbitopathy
    • Montpellier, France
      Uhmontpellier
    2022-01-10
    Jan 10, 2022
    M
    Recruiting
    • Graves Orbitopathy
    • rabbit anti-thymocyte globulin
    • Katowice, Silesia, Poland
      Department of Internal Medicine and Oncological Chemotherapy, Me
    2022-01-14
    Jan 14, 2022
    T
    Active, not recruiting
    • Graves Ophthalmopathy
    • Aarhus C, Central Denmark Region, Denmark
    • +1 more
    2022-02-21
    Feb 21, 2022
    U
    Completed
    • Graves' Ophthalmopathy
    • Hypercholesterolemia
    • No intervention
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology I and II
    2017-08-10
    Aug 10, 2017
    A
    Completed
    • Graves' Disease
    • K1-70 intramuscular or K1-70 intravenous
    • Liverpool, United Kingdom
    • +1 more
    2021-05-18
    May 18, 2021
    T
    Recruiting
    • Graves Disease
    • Echopulse
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    2021-04-27
    Apr 27, 2021
    I
    Terminated
    • Graves' Ophthalmopathy (GO)
    • RVT-1401 (Administered via subcutaneous injection)
    • Placebo (Administered via subcutaneous injection)
    • Beverly Hills, California
    • +24 more
    2021-05-31
    May 31, 2021